Bottom line
THISX vs JEHSX: the short answer
THISX (T. Rowe Price Health Sciences Fund, Inc.) and JEHSX (Health Sciences Trust) are both mutual funds.
THISX is cheaper at 0.68% vs 1.04% — a difference of $36 a year per $10,000 invested.
Over five years, THISX returned +4.3% a year vs +4.2% for JEHSX.
Updated Nov 19, 2026
THISX vs JEHSX side by side
| THISX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | T. Rowe Price | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 1.04% |
| Annual cost per $10k | $68 | $104 |
| 10-yr cost on $10k (prospectus) | $847 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | — | 0.05% |
| 1-yr return | +17.9% | +19.5% |
| 5-yr return (annualized) | +4.3% | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | +23.5% | +23.6% |
| Worst quarter | −15.8% | −16.1% |
| Net assets (fund) | $11.9B | $251.3M |
| Number of holdings | 279 | 173 |
| Portfolio turnover | 62% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
24 of THISX's top 25 holdings also appear in JEHSX's top 25.
| Holding | THISX | JEHSX |
|---|---|---|
| Eli Lilly & Co | 14.28% | 14.30% |
| Johnson & Johnson | 6.63% | 6.33% |
| Unitedhealth Group Inc | 5.99% | 5.95% |
| Abbvie Inc | 5.10% | 5.28% |
| Merck & Co. Inc. | 4.01% | 4.21% |
| Gilead Sciences Inc | 2.82% | 2.95% |
| Thermo Fisher Scientific Inc | 2.52% | 2.67% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.38% |
| Bristol-myers Squibb Co | 2.11% | 2.22% |
| Abbott Laboratories | 1.89% | 2.00% |
| Intuitive Surgical Inc | 1.87% | 1.98% |
| Amgen Inc | 1.82% | 1.90% |
| Stryker Corp | 1.78% | 1.87% |
| Elevance Health Inc | 1.53% | 1.63% |
| Natera Inc | 1.44% | 1.49% |
Source: SEC Form N-PORT
THISX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between THISX and JEHSX?
THISX (T. Rowe Price Health Sciences Fund, Inc.) and JEHSX (Health Sciences Trust) are both mutual funds. THISX is cheaper at 0.68% vs 1.04% — a difference of $36 a year per $10,000 invested.
Which is cheaper, THISX or JEHSX?
THISX has the lower expense ratio (0.68%).
Should I own both THISX and JEHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.